Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction and lipid disorders.

M Schachter1

  • 1Department of Clinical Pharmacology, Imperial College School of Medicine, St Mary's Hospital, London, W2. m.schachter@ic.ac.uk

Current Medical Research and Opinion
|May 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morphology assessment and fluorescence in situ hybridization of the same spermatozoon using a computerized cell-scanning system.

Human reproduction (Oxford, England)·2006
Same author

Meiotic arrest in vitro by phosphodiesterase 3-inhibitor enhances maturation capacity of human oocytes and allows subsequent embryonic development.

Biology of reproduction·2005
Same author

The use of ezetimibe in achieving low density lipoprotein lowering goals in clinical practice: position statement of a United Kingdom consensus panel.

Current medical research and opinion·2005
Same author

The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes.

Human reproduction (Oxford, England)·2004
Same author

Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.

International journal of clinical practice·2003
Same author

Coasting-what is the best formula?

Human reproduction (Oxford, England)·2003
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
Same journal

Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

Current medical research and opinion·2026
See all related articles

High cholesterol and low HDL cholesterol increase erectile dysfunction (ED) risk, linked to atherosclerosis. Further research is needed to determine if treating dyslipidemia with statins or fibrates prevents or treats ED.

Area of Science:

  • Cardiovascular Health
  • Metabolic Disorders
  • Men's Health

Background:

  • Epidemiological studies link elevated serum cholesterol and low high-density lipoprotein (HDL) cholesterol to increased erectile dysfunction (ED) risk.
  • This association highlights the connection between ED and atherosclerosis, a condition involving plaque buildup in arteries.
  • The potential benefits of correcting dyslipidemia for ED prevention or treatment remain unestablished.

Purpose of the Study:

  • To investigate whether correcting dyslipidemia can reduce the risk of developing ED.
  • To determine if interventions for dyslipidemia can improve symptoms in patients with existing ED.
  • To address the need for well-designed trials on the efficacy of statins and fibrates in ED management.

Main Methods:

Related Experiment Videos

  • Review of epidemiological data correlating lipid profiles with ED incidence.
  • Analysis of existing literature on dyslipidemia treatments and their impact on cardiovascular health.
  • Identification of knowledge gaps regarding the therapeutic role of lipid-lowering agents in ED.

    • Main Results:

    • Established link between dyslipidemia (high cholesterol, low HDL) and increased ED risk.
    • Atherosclerosis identified as a common underlying factor for both conditions.
    • Uncertainty regarding the efficacy of lipid-modifying interventions in preventing or treating ED.

    Conclusions:

    • Dyslipidemia is a significant risk factor for erectile dysfunction.
    • Further clinical trials are necessary to evaluate the effectiveness of statins and fibrates in managing ED.
    • The potential for ED as a side effect of certain lipid-lowering medications requires consideration.